Team
In2Cell was founded on more than a decade of hands-on cancer research. The platform is being built by people who have studied, at first hand, how tumours respond to drugs and how they resist them.
Guiding In2Cell's scientific strategy and platform direction, bringing deep biotech experience to the POLEX programme.
twhite@in2cell.comCancer biologist with eight years in drug-resistance research and long-read sequencing, guiding the science behind POLEX.
skumar@in2cell.comDeveloping the organoid and sequencing workflows behind POLEX at the bench.
kporova@in2cell.comWorking at the bench on the organoid and sequencing science that powers POLEX.
spatel@in2cell.comLeads people and hiring as In2Cell builds out its founding team.
vwarren@in2cell.comSupports hiring, people operations, and day-to-day team coordination.
sasisubra@in2cell.comFor questions, partnerships, and support, our customer care team is here to help.
hres@in2cell.comWe are a small team, growing deliberately. If you want to help take the guesswork out of cancer treatment, we would love to hear from you.